PTSD Trial, Recruiting NCT07107269 Sponsor: Colorado State University Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT07107269
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 to 65 who have been diagnosed with PTSD
  • People with a Body Mass Index (BMI) under 35 (a measure of body weight relative to height)
  • People who are in general good health aside from their PTSD diagnosis
  • People who are willing and able to follow the study schedule and attend all required clinic visits

Who may not be able to join:

  • People who have used antibiotics in the three months before the study starts
  • People with a BMI of 35 or above
  • People who follow a vegan or vegetarian diet
  • People who have an allergy to any of the foods used in the study drinks
  • People who have recently changed their medications or do not have a stable medication routine (medications other than antibiotics are generally acceptable if the person has been on the same regimen for at least two months before the study and continues it throughout)
  • People who have been diagnosed with a gastrointestinal disease, cancer, cardiovascular disease, diabetes, or an autoimmune disease
  • People who are pregnant or breastfeeding
  • People who are unable to commit to the study requirements, which include drinking the provided beverages daily, providing stool and blood samples, tracking bowel movements and symptoms, and attending scheduled appointments
  • People who take certain supplements (eligibility based on supplement use is reviewed case-by-case by the trial site)
  • People who use antibiotics or change their medications during the study may be removed from the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tiffany Weir, PhD, Colorado State University

Phone: (970) 491-4631

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Colorado State University
Registry
ClinicalTrials.gov
Start date
25 June 2025
Est. completion
30 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Changes in self-assessed severity of post-traumatic stress disorder (PTSD) symptoms; Gut Microbiota Richness; Gut microbiota diversity; C-reactive protein in plasma

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov